BGI News More
- BGI Launches the Latest Desktop Sequencer BGISEQ-50
- International Science Community Welcomes China National GeneBank Opening
- BGI and Clearbridge BioMedics Partner to Develop China CTC Liquid Biopsy Market towards Precision Medicine
- Tadataka Yamada, M.D., Former President of Global Health Program at Bill & Melinda Gates Foundation, Former Chairman of R&D at GlaxoSmithKline, Joins BGI
- The international Sc2.0 Project is on track to build the world’s first synthetic yeast genome
- Avian-specific conserved genomic elements play important regulatory roles in the macroevolution of avian-specific features
- The Evolution of Chronic Lymphocytic Leukemia Revealed
- BGI involved in publication of the first seahorse genome in Nature
- Leading Health Organizations in Canada and China Teaming up to Accelerate Precision Medicine
- World’s largest genomic organisation to collaborate with leading Queensland researchers
- Ranomics Partners with BGI to Classify Variants of Unknown Significance
- BGI and UW collaborate on precision medicine development
- Chinese innovation : BGI’s code for success
- Prof. Huanming Yang to Receive Membership from Royal Danish Academy of Sciences and Letters
- UW, Chinese genomics group forge new partnership to advance biomedical research
- Mapping more genomes will create a healthcare 'big data revolution'
Tel: +86-755-36307212Email: firstname.lastname@example.org
Chinese innovation : BGI’s code for success
Publish Date: 2015-02-26
In 2010, Bill Gates visited an unremarkable building in an industrial estate on the outskirts of Shenzhen, China. With row after row of high-tech machinery humming inside, the place could easily be mistaken for an anonymous data warehouse.
But Mr Gates and Ray Yip, head of the Gates Foundation’s China operation, saw something else that day. As they toured the BGI headquarters, the two men were stunned by the ambition of the scientists working at the biotech company. Inside, more than 150 state of the art genetic sequencing machines were analysing the equivalent of thousands of human genomes a day.
The company is working towards a goal of building a huge library based on the DNA of many millions of people. BGI executives see this not as the end-game, but as the springboard for new drug discoveries, advanced genetic research and a transformation of public health policy.
Read the full article : Chinese innovation : BGI’s code for success ( Financial Times )